SCHEMBL5200679

SCHEMBL5200679

CS(=O)(=O)n1ccc2ccc(CC3=NCCN3)cc21

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.53
CYP2D6 P10635 2/20 0.53
NFKB1 P19838 1/20 0.53
RAD52 P43351 1/20 0.48
HTR6 P50406 1/20 0.48
HTR1D P28221 5/20 0.46
HTR1B P28222 4/20 0.45
ADRA2A P08913 2/20 0.45
ADRA2B P18089 2/20 0.45
ADRA2C P18825 2/20 0.45
ADRA1D P25100 2/20 0.45
ADRA1A P35348 2/20 0.45
ADRA1B P35368 2/20 0.45
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
TSHR P16473 1/20 0.43
PTGIR P43119 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5201826 0.99 TAAR1 (0.52) TAAR1CYP2D6NFKB1RAD52HTR6
SCHEMBL5202333 0.81 NISCH (0.56) TAAR1CYP2D6NFKB1HTR6ADRA2A
Hydrochloric Acid SCHEMBL8065503 0.81 NISCH (0.55) TAAR1CYP2D6NFKB1HTR6ADRA2A
SCHEMBL14340649 0.74 HTR6 (0.54) HTR6LMNACYP1A2
SCHEMBL5206534 0.73 HTR6 (0.52) HTR6
SCHEMBL5202098 0.73 HTR6 (0.52) HTR6
SCHEMBL953099 0.70 TAAR1 (1.00) TAAR1CYP2D6NFKB1HTR1DHTR1B
SCHEMBL5204217 0.70 HTR6 (0.49) HTR6
SCHEMBL4993472 0.69 RAD52 (0.49) TAAR1CYP2D6NFKB1RAD52HTR1D
SCHEMBL5200888 0.69 RAD52 (0.49) TAAR1CYP2D6NFKB1RAD52HTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0887346-B1 N-Phenyl-alkylsulfonamide derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists HOFFMANN LA ROCHE (CH) 2007-12-12 EP disclosed
US-6057349-A ALPHA.SUB.1A/1L AGONISTS USED IN THE TREATMENT OF VARIOUS DISEASE STATES SUCH AS URINARY INCONTINENCE, NASAL CONGESTION, PRIAPISM, DEPRESSION, ANXIETY, DEMENTIA, SENILITY, ALZHEIMER'S, DEFICIENCIES IN ATTENTIVENESS AND COGNITION, AND F. HOFFMAN LA ROCHE AG (CH) 2000-05-02 US disclosed
US-5952362-A INHIBITOR OF GLYCOGEN PHOSPHORYLASE ENZYMETIC ACTIVITY AND GLUCOSE ACITIVITY SYNTEX (U.S.A) INC. (US) 1999-09-14 US disclosed
EP-0887346-A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists F. HOFFMANN-LA ROCHE AG (CH) 1998-12-30 EP disclosed